Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Income from Continuing Operations (2020 - 2025)

Historic Income from Continuing Operations for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $1.1 million.

  • LifeStance Health's Income from Continuing Operations rose 11807.96% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.1 million, marking a year-over-year increase of 8942.7%. This contributed to the annual value of -$58.4 million for FY2024, which is 6864.58% up from last year.
  • As of Q3 2025, LifeStance Health's Income from Continuing Operations stood at $1.1 million, which was up 11807.96% from -$3.8 million recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Income from Continuing Operations registered a high of $1.1 million during Q3 2025, and its lowest value of -$120.5 million during Q3 2021.
  • For the 5-year period, LifeStance Health's Income from Continuing Operations averaged around -$40.5 million, with its median value being -$37.9 million (2022).
  • Per our database at Business Quant, LifeStance Health's Income from Continuing Operations plummeted by 355670.92% in 2021 and then surged by 11807.96% in 2025.
  • Quarter analysis of 5 years shows LifeStance Health's Income from Continuing Operations stood at -$108.0 million in 2021, then skyrocketed by 56.81% to -$46.7 million in 2022, then grew by 3.64% to -$45.0 million in 2023, then surged by 82.05% to -$8.1 million in 2024, then soared by 113.35% to $1.1 million in 2025.
  • Its Income from Continuing Operations was $1.1 million in Q3 2025, compared to -$3.8 million in Q2 2025 and $709000.0 in Q1 2025.